This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Oy Juvantia Pharma Ltd., Siegfried Wurster, Other. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 1 
1 out of 834,570 Years Active: 2003-2010
Title: Andrei Tauber: Innovator in the Field of Pharmacology
Introduction
Andrei Tauber, based in Helsinki, Finland, is a distinguished inventor with a significant contribution to the field of pharmacology. He holds three patents, focusing on innovative solutions aimed at advancing medical treatment and diagnosis. His work centers on developing compounds that interact with specific receptors, showcasing a blend of creativity and scientific rigor.
Latest Patents
One of Andrei's latest patents involves "Somatostatin receptor 1 and/or 4 selective agonists and antagonists." This invention pertains to (hetero)arylsulfonylamino-based peptidomimetics of a defined formula, which possess high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and SSTR4. These compounds can be employed for the treatment or diagnosis of various diseases or conditions where interaction with these receptors is beneficial. Additionally, he has developed compounds useful for the treatment or prevention of diseases mediated by the alpha-2B-adrenoceptor, marking a significant advancement in medicinal chemistry.
Career Highlights
Throughout his career, Andrei has been associated with notable companies, including Siegfried Wurster and Oy Juvantia Pharma Ltd. His experience in these organizations has allowed him to foster innovation and enhance therapeutic methodologies, contributing to various medical advancements.
Collaborations
Andrei Tauber has collaborated with accomplished colleagues such as Harri Salo and Siegfried Wurster. Together, they have explored groundbreaking ideas and developments in the pharmaceutical sector, illustrating the power of teamwork in advancing health science.
Conclusion
Andrei Tauber stands as a prominent figure in the realm of pharmaceutical innovation. With a focus on developing selective receptor compounds, he continues to pave the way for new treatment possibilities. His substantial patent portfolio not only highlights his inventive spirit but also reinforces the importance of collaboration and innovation in addressing medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile